Thorac Cardiovasc Surg 2003; 51(3): 159-161
DOI: 10.1055/s-2003-40316
Original Thoracic
© Georg Thieme Verlag Stuttgart · New York

Resection of Bronchopulmonary Cancers Invading the Left Atrium - Benefit of Cardiopulmonary Bypass

O.  Baron1 , J.  Jouan1 , C.  Sagan2 , P.  Despins1 , J.-L.  Michaud1 , D.  Duveau1
  • 1Cardiothoracic and Vascular Surgery Department. R & G Laënnec Hospital, Nantes, France
  • 2Anatomo-Pathology Department. R & G Laënnec Hospital, Nantes, France
Further Information

Publication History

Received: December 4, 2002

Publication Date:
30 June 2003 (online)

Abstract

Aims: Cardiopulmonary bypass (CPB) for extended lung resections involving great vessels and other mediastinal organs remains controversial, especially due to CPB-related haemorrhagic and immunological issues. Here, we will retrospectively analyse the results obtained with such procedure. Material and Methods: Between January 1994 and February 2001, four patients underwent surgery under CPB for lung carcinoma in our department. Three patients were male and one female; mean age was 58.8 ± 6.3 years. The patients suffered from malignant pulmonary lesions involving the left atrium (T4 or stage IIIb) - two epidermoid carcinoma, one adenocarcinoma and one large-cell carcinoma. Procedures were performed under complete CPB with aortic cross-clamping in all but one patient who underwent hypothermic ventricular fibrillation. Mean CPB duration was 86.7 ± 26.5 min. Results: There were no hospital mortalities (D30). Mean duration for assisted ventilated support was 9.5 ± 2.5 hours, 2.5 ± 1 days for ICU stay and 14.3 ± 1 days for hospital stay. Operation-related complications were rare. Two patients presented with transient postoperative atrial fibrillation. Only one patient had to undergo reoperation for compressive haemopericardium drainage at D23. The mean quantity of transfused packed red blood cell packs was 2.7 ± 1.7. Two patients survived over three years after surgery and one patient is still alive at 72 months without any recurrent symptom. Conclusion: In some cases of T4 lung cancer considered inoperable, CPB permits extended lung resections offering significant hope for survival at an acceptable operative risk.

References

  • 1 Raemdonck D E Van, Schneider A, Ginsberg R J. Surgical Treatment for Higher Stage Non-Small-Cell Lung Cancer.  Ann Thorac Surg. 1992;  54 999-1013
  • 2 Grunenwald D, Chevalier T Le. Re-stage IIIA Category of Non-Small-Cell Lung Cancer: a New Proposal.  J Natl Cancer Inst. 1997;  89 88-89
  • 3 International Union Against Cancer .TNM Classification of Malignant Tumors 5th ed. New York: Wiley-Liss 1997: 93-97
  • 4 Mountain C F. Revisions in the International System for Staging Lung Cancer.  Chest. 1997;  111 1710-1717
  • 5 André F, Grunenwald D, Girard P, Houtte P Van, Pastorino U, Chevalier T Le. Cancers bronchiques non á petites cellules avec envahissement médiastinal.  Bull Cancer. 1999;  86 867-870
  • 6 Tsuchiya R, Asamura H, Kondo H, Goya T, Naruke T. Extended Resection of the Left Atrium, Great Vessels, or Both for Lung Cancer.  Ann Thorac Surg. 1994;  57 960-965
  • 7 Regnard J F, Spaggiari L. Résultats des exérèses pulmonaires élargies à la caréne, à la veine cave supérieure et à l'oreillette gauche (T4). Huitième Journée de Pathologie Thoracique de L'Hôpital de Marie-Lannelongue 29 mars 1996. Paris; Laboratoire Roger Bellon Edit
  • 8 Shirakusa T, Kimura M. Partial atrial resection in advanced lung carcinoma with and without cardiopulmonary bypass.  Thorax. 1991;  46 484-487
  • 9 Woods F M, Neptune W B, Palachi A. Resection of the carina and main stem bronchi with the use of extracorporeal circulation.  N Engl J Med. 1961;  264 492-494
  • 10 Toty L, Piwnica A, Israel-Asselin R, Gilbert J, Weiss M, Mazabraud A. Volumineux Angio-histo-cyto-fibrome du hile pulmonaire droit. Pneumonectomie sous CEC.  Ann Chir Thor Card. 1966 ;  5 137-147
  • 11 Bailey C P, Schechter D C, Folks F S. Extending operability of lung cancer involving the heart and great vessels.  Ann Thorac Surg. 1971;  11 140-150
  • 12 Klepetko W, Wisser W, Birsan T. et al . T4 lung tumors with infiltration of the thoracic aorta: is an operation reasonable?.  Ann Thorac Surg. 1999;  67 340-344
  • 13 Ricci C, Rendina E A, Venuta F, Ciriaco P P, Giacomo T De, Fada G F. Reconstruction of the pulmonary artery in patients with lung cancer.  Ann thorac Surg. 1994;  57 627-633
  • 14 Zetter B R. The cellular basis of site specific metastasis.  N Engl J Med. 1990;  322 605-612
  • 15 Rivière A Brutel de la, Knaepen P, Swieten H Van, Vanderschueren R, Ernst J, Bosch J Van den. Concomitant open heart surgery and pulmonary resection for lung cancer.  Eur J Cardiothorac Surg. 1995;  9 310-314
  • 16 Miller D L, Orszulak T A, Pairolero P C, Trasteek V F, Schaff H V. Combined operation for lung cancer and cardiac disease.  Ann Thorac Surg. 1994;  58 989-994
  • 17 Rao V, Todd T RJ, Weisel R D. et al . Results of Combined Pulmonary Resection and Cardiac Operation.  Ann Thorac Surg. 1996;  62 342-347
  • 18 Kirklin J K, Westaby S, Blackstone E H, Kirklin J W, Chenoweth D E, Pacifico A D. Complement and the damaging effects of cardiopulmonary bypass.  J Thorac Cardiovasc Surg. 1983;  86 845-857

MD Olivier Baron

Service de Chirurgie Cardio-thoracique et Vasculaire, Hôpital R & G Laënnec

Bld J. Monod

44093 Nantes cedex 1

France

Phone: +33/2/40165084

Fax: +33/2/40165402

Email: Olivier.baron@chu-nantes.fr

    >